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ABSTRACT 
 
Motivation: Mitochondria are the principal site of important cellular functions including ATP production via oxidative 
phosphorylation (OXPHOS) but also play a central role in cell physiology.OXPHOS comprises five respiratory complexes 
(RCs). Complex II or succinate dehydrogenase (SDH) is a heterotetrameric nuclear-encoded complex composed of four 
subunits (SDHA, SDHB, SDHC, SDHD). It´s responsible for transferring electrons into mitochondrial respiratory chain for ATP 
production but also for the oxidation of succinate to fumarate in the tricarboxylic acid (TCA) cycle.Changes in TCA cycle have 
been considered as potential mechanisms of aerobic glycolysis that contributes to the alteration of cellular metabolism with 
implications in tumorigenesis. It has been reported that polymorphisms in SDHD are associated with early recurrence of 
hepatocellular carcinoma. Our goal was to study the role of SDHD in tumor and no tumor liver cells. 
Methods: Murine hepatocytic cells, AML12 and Hepa1-6 were obtained from the ATCC. In order to analyze the function of the 
SDHD we used murine-SDHD-specific siRNA and control siRNA. SDHD overexpression was performed using a plasmid 
vectors with murine SDHD constructed using standard molecular cloning techniques. In both cases cells were transfected with 
lipofectamine.To analyze metabolic changes induced by SDHD we performed real-time PCR. Proteins were examined by 
Western blots. Cell viability assay, colony formation assay and wound healing assay have been performed to determinate cell 
survival, proliferation and migration. 
Results: Inhibition of SDHD in hepatocytic cells increased glycolytic genes at 48 h and 72 h after transfection compared to 
controls, with higher rate in the Hepa1-6 than AML12 cells. Overexpression of SDHD, did not induce significant changes in 
metabolic genes as compared to control cells. Furthermore, we observed that the inhibition of SDHD in hepatocytic cells 
produced an increase in cell death. In addition, clonogenic growth decreased greatly, resulting in reduced colony size and 
numbers in SDHD-inhibiting cells. In a wound healing migration assay, cell confluence was reached significantly later in the 
SDHD-inhibiting cells than the si-control transfected cells. Finally, the cell cycle analyses showed that SDHD-knockdown cells 
showed less percentage of cells in G1 than control cells. 
Conclusions: Our findings suggest that SDHD plays an important role in the survival, growth and cellular proliferation. 
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